MYO1D mutation identified as a key factor in sperm defects and congenital conditions

The research uncovers a novel variant in the MYO1D gene that is linked to laterality defects, congenital heart diseases, and sperm defects in humans.

Embecta gets FDA nod for insulin patch pump

Dive Brief: Embecta received 510(k) clearance from the Food and Drug Administration on Friday for its first insulin patch pump. The device can be used

September 3, 2024

Stenting, TAVR Make Sense Packaged Together for Some Patients

LONDON — Some individuals already undergoing transcatheter aortic valve replacement (TAVR, also TAVI) might as well get coronary lesions revascularized around the same time, according

September 2, 2024

Lilly inks radiopharma deal with Radionetics, with rights to buy the biotech

Eli Lilly is further delving into the radiopharmaceutical field with a $140 million upfront deal with Radionetics Oncology. The strategic pact with the San Diego

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.